Just discovered the new updated edition of Psoriatic Arthritis (the facts) is published this month. Available to pre-order from Amazon:
http://www.amazon.co.uk/dp/0199692092/ref=pe_385721_37986871_TE_item
This is good news! Thanks, Jules. I was wondering who the new co-author Cheryl Rosen is, and looked her up. She’s a senior dermatologist at the same hospital as the other two authors. Maybe the new edition will have a bit more about skin manifestations in it.
I’m looking forward to getting my e-copy as soon as it becomes available.
Time to start promoting the new edition, Seenie. You might get a cut depending on sales...
Seenie said:
I'm looking forward to getting my e-copy as soon as it becomes available.
LOL!
Just pre-ordered! Thanks so much for posting about the updated book! I'm excited, because so many new drugs have come on the market since the last edition, and it seems like the understanding of PsA is really moving quickly. I hope to find new information in the new edition.
Yep, I've pre-ordered too .... mine here in the UK has an expected delivery first week of April.
I've just started on Simponi which isn't mentioned in current version so I'm also excited to see what new information is published by such world renowned experts
PS. Have been reluctant to post about what's been happening since my first injection of golimumab on Saturday 1st ..... will just say there may be some subtle signs for cautious optimism ...... but don't want to jinx myself.
Has anyone researched how much funding the writers of that book got from pharmaceutical companies? I know that Dr. Rosen's dermatological research was funded in great part by an organization with very deep financial ties to the pharmaceutical industry. The book really seemed to promote the use of biologics- which are really big money makers for those companies forever, basically, because of how inherently expensive and difficult it is to produce biologics. Literature based on research done other than at Toronto and Oxford seems to lean more toward only using biologics if there is axial involvement, but I haven't been looking that long.
I haven't but having friends, family and fomer colleagues connected with the medical/pharmaceutical industry I still have faith in most medical professionals integrity. Funding from the commercial industry is what enables many excellent medical professionals to conduct research alongside their (often poorly funded) regular healthcare jobs. I hope I'm not speaking out of turn by saying that one of our moderators has one of these authors as their rheumy ...... and finds them nothing but an outstanding medical professional whose judgement is balanced and focused on the patients best interests. My own rheumy is heavily involved in research and I have never felt that his judgement has been influenced by any commercial interest.
Wonderful! Thank you, Jules! I have worried about that. I am definitely grateful that there are companies with enough resources to fund these medications.
Good point, Rosen! It’s hard to find large-scale medical research that isn’t at least partially funded by Big Pharma. And it always raises concerns, it does for me, anyway. The Toronto Clinic is one of (if not the) world’s largest research clinics for this disease. Yes, they receive funding from the drug companies. On the other side of the coin, their research is widely and critically peer-reviewed by clinicians all over the world.
Our stats and research man, tntlamb, would be able to explain it all better than I can. (Too bad he’s sidelined, recovering from surgery.) But Toronto’s samples are very large, and therefore more likely to yield reliable research findings than research done with smaller patient groups. And yes, as Jules mentioned, I’m in the Toronto group.
Full disclosure here for me. I discovered the Gladman and Chandran book a couple of years ago. I found it extremely informative and helpful in understanding my disease. I had finished reading it, when I wondered “Who are these people, anyway?”. When I realized they happened to be within striking distance of home, I got a referral. I am very fortunate to have Dr. Chandran as my rheumatologist. That book led to my discovering the clinic.
You could call me a shill for the book. 
But I recommend it not because I go to that clinic, but because the book has been so very helpful to me. Others have found the same.
I would be interested to hear what new information is provided in this new edition. Please let us know. Thanks!
Thank you-I just ordered.
Just ordered, thank you for sharing Jules!! :-)
Once it's here and I've read it I'll be happy to do a note on what subjects have been updated/expanded.
dandlyons said:
I would be interested to hear what new information is provided in this new edition. Please let us know. Thanks!
My pleasure .... was excited when I found out about it and knew lots of members here would be too :-)
TaraLynn said:
Just ordered, thank you for sharing Jules!! :-)
Perfect. Thank you. 
Jules said:
I haven’t but having friends, family and fomer colleagues connected with the medical/pharmaceutical industry I still have faith in most medical professionals integrity. Funding from the commercial industry is what enables many excellent medical professionals to conduct research alongside their (often poorly funded) regular healthcare jobs. I hope I’m not speaking out of turn by saying that one of our moderators has one of these authors as their rheumy … and finds them nothing but an outstanding medical professional whose judgement is balanced and focused on the patients best interests. My own rheumy is heavily involved in research and I have never felt that his judgement has been influenced by any commercial interest.
Just heard from Amazon, new edition has now been released after a delay and it's on it's way. Can't wait and will post a summary of new content when I've read it.
Thanks Jules, I just ordered it on Amazon. I read a few reviews that found it a bit technical, but as a former Nurse I should be able to comprehend it. Dealing with this for over 30 years, I am always anxious to hear new discoveries and treatments.
Ok, it arrived this morning so I've had my nose buried in it since lunchtime.
It is much more clinically technical than the previous version and reading their splurb this version it is aimed at "the busy practitioner ... trainees and specialists in rheumatology and dermatology". That said, I've still been able to follow it pretty well, and a quick look-up of the meanings of a few medical terms on the intenet has filled in my gaps. They include alot of statistical data which I don't fully understand (this is right up lambs street!) but the pertinent points are clear or well summarised and in some cases not necessarily something I felt I needed to know.
It includes current studies, trials results, data and detailed chapters on classification, diagnosis (including differential diagnosis), assessment criteria, clinical and laboratory features, imaging modalities, skin and nail involvement, treatments, surgery, prognosis and the future. Alot of very good new information on enthesis/enthesitis. Each chapter ends with a list of further reading references.
This is going to sound totally crazy but my 'lightbulb' moment was simply reading about the assessment of tenderness in PsA patients who are not as tender as patients with RA "Indeed, one needs to apply enough pressure to blanch one's own finger to ensure that tenderness is not missed". Thank you Drs Gladman/Chandran, I'm going to photocopy this and hand it to my rheumy nurse who uses a completely inadequate feather-light touch.
In looking to the future the authors have identified areas where challenges remain and research continues, including that "a significant proportion of patients fail treatment with anti-TNF agents ........ New agents that are helpful in such patients need to be developed, and the reasons for failure to respond to anti-TNF agents understood."
My conclusion is that having both versions of the book is best. The 2009 version provides a good, detailed, patient orientated information but the new version steps it up a level or two ....... but if you really want to understand the most current knowledge, ask challenging questions about your disease progression/imaging results/treatments then the 2014 version is an EXCELLENT add on. The 2014 version might be a bit too much for newbies in the very early days.
For what it costs under £20, well worth buying.